Delivery Order SPE2D021DA002-SPE2D324F4753
Award Date 1/26/24
Potential Completion Date 1/29/24
Potential Value $17K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $16,574.04 firm-fixed-price contract is for the delivery of the drug Isentress 400 mg Tablet, with a performance period through March 15, 2024. DMS Pharmaceutical Group Inc. holds a larger $4,999,999 indefinite delivery contract with the DLA, contract 4600082013 under the SPE2DB...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) under the DLA Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $24,861.06, is for the delivery of the pharmaceutical product Isentress 400 mg tablets. The contract has a firm fixed-price pricing type and a completion date of July 5, 2024. DMS Pharmaceutical Group Inc. holds a larger...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,381.17, is for the delivery of Isentress 400 mg tablets. This order is part of a larger indefinite delivery contract, SPE2DB, that DMS Pharmaceutical Group holds with DLA, valued up to $4,999,999 through 2025. Through this IDV, DMS Pharmaceutical provides a wide...
- This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,905.85 firm fixed-price contract is for the supply of Isentress 400 mg tablets, with a period of performance through March 29, 2024. The award is issued under DMS Pharmaceutical Group's $4,999,999 indefinite delivery contract SPE2DB, which enables the...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $2,762.34 order is for ISENTRESS 400 MG TABLET, a branded pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $4,999,999 that DMS Pharmaceutical Group holds with DLA for a broad range of pharmaceutical items to support...
- This federal contract award, valued at $13,811.70, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Isentress 400 mg tablets, with a completion date of June 25, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 25, 2025, to supply Isentress 400 mg tablets (60-count units) to the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, valued at $20,936.20, represents a single-award contract with an ultimate completion date of August 26, 2025. The award was made without a set-aside designation, enabling DMS...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $11,049.36 contract provides for the delivery of Isentress 400 mg tablets to support the medical supply needs of U.S. government agencies. This order is issued against DMS Pharmaceutical Group's indefinite delivery contract with DLA, contract 4600082013 under the SPE2DB program, which has a ceiling value of up...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,650.54 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of ISENTRESS 100 MG TABLET CHEW UU 60S, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA...
- This is a $1,381.17 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of ISENTRESS 400 mg tablets, with a period of performance through May 17, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D324F4753Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $16,574.04 firm-fixed-price contract is for the delivery of Isentress 400 mg tablets, a prescription pharmaceutical product. The contract has a completion date of January 29, 2024. DMS Pharmaceutical Group Inc. holds an indefinite delivery contract, SPE2DB, with the DLA valued up to $4,999,999 through 2025, which enables the agency to issue delivery orders for a broad range of pharmaceutical items to support military medical facilities worldwide. This contract award does not have a set-aside designation.
Generated 4/26/24, 11:23 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.6k | 1/26/24 |